Results 221 to 230 of about 13,496,740 (294)

A food system transformation pathway reconciles 1.5 °C global warming with improved health, environment and social inclusion. [PDF]

Nat Food
Bodirsky BL, Beier F, Humpenöder F, Leip D, Crawford MS, Chen DM, von Jeetze P, Springmann M, Soergel B, Nicholls Z, Strefler J, Lewis J, Heinke J, Müller C, Karstens K, Weindl I, Stevanović M, Rein P, Sauer P, Mishra A, Bacca EJM, Köberle AC, Wang X, Singh V, Hunecke C, Collignon Q, Schreinemachers P, Dietz S, Kanbur R, Dietrich JP, Lotze-Campen H, Popp A.   +31 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Between rights and reality: patient perceptions of social inclusion in a forensic psychiatric clinic implementing safewards. [PDF]

Front Psychiatry
Pelto-Piri V, Kjellin L, Kronman L, Wetterling J, Björkdahl A.   +4 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

The relationship between leisure involvement and social inclusion among Chinese older adults: the mediating roles of flow experience and fear of missing out. [PDF]

Front Psychol
Hu J.
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Factors Associated With Social Inclusion and Labour Status in People With Intellectual Disabilities, From Urban and Rural Areas of Peru. [PDF]

J Appl Res Intellect Disabil
Boluarte Carbajal A, Chávez-Ventura G, Lezcano De La Cruz SE, López ACZ.   +3 more
europepmc   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

Moving beyond IPS: a person-centred approach to social inclusion and mental health - ERRATUM. [PDF]

BJPsych Bull
Greenburgh A, Bertram M, Baldwin H, Williams S, McDonald S, Morgan C.   +5 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source